RealSeq develops groundbreaking RNA fragmentomics technology to allow real-time detection of disease dramatically improving diagnosis and treatment.
RiboMarkers are next generation cell free (cf)RNA fragmentomics-based diagnostics that are dynamic reporters able to predict dissemination of disease. We are developing and commercializing a liquid biopsy platform for debilitating fungal pathogens such as Valley Fever that are currently poorly managed yet rapidly increasing due to factors such as climate change with global implications.
Our core expertise includes innovative proprietary technologies for bias-free small RNA/miRNA NGS library construction, targeted NGS tools, and cf-RNA analysis (liquid biopsy).
Company Details
- Employees
- 15
- Founded
- -
- Address
- 2125 Delaware Ave,
- se****@****ces.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- realseqbiosciences.com
- Keywords
- at RIS..
- HQ
- Santa Cruz, California
Realseq Biosciences Questions
Realseq Biosciences's website is realseqbiosciences.com
Realseq Biosciences's LinkedIn profile is https://www.linkedin.com/company/realseq-biosciences
Realseq Biosciences has
15 employees.
View email and phone details for 15
employees at Realseq Biosciences.
Realseq Biosciences's industry is
Biotechnology Research
Realseq Biosciences's top competitors are
Variantyx,
Level Bio Ab,
Infinity Bio, Inc.,
Reveal Genomics,
Btu. Biotech Company,
Preanalytix Gmbh,
Cleanna,
Depixus,
Singleron Biotechnologies,
Abbelight.
Realseq Biosciences's support email address is sequencing@realseqbiosciences.com
Realseq Biosciences's categories are Biotechnology Research
Realseq Biosciences's founding year is 2019
